Financials
- Market Capitalization 585.74 M
- Employee 200
- Founded 2015
- CEO N/A
- Website www.ars-pharma.com
- Headquarter Delaware, United States
- FIGI BBG00FZQGXG3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.69
Relación precio/flujo de caja
6.78
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2800 | ALT Altimmune, Inc. - Common Stock | 3.11 USD | -4.01% | 0.00% | +4.01% | -18.37% | 604.95 M USD | ||
| 2808 | ARVN Arvinas, Inc. - Common Stock | 9.18 USD | -0.65% | -2.13% | +11.41% | -1.29% | 600.25 M USD | ||
| 2831 | MPLT MapLight Therapeutics, Inc. - Common Stock | 12.60 USD | +0.48% | +12.40% | -12.62% | -33.68% | 584.36 M USD | ||
| 2855 | VALN Valneva SE - American Depositary Shares | 6.43 USD | -2.28% | -3.74% | +26.33% | -20.22% | 557.93 M USD |